Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics, E-Book
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more. Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both; advantages of total body PET imaging in hematological malignancies; applications of FDG-...
Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more. Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both; advantages of total body PET imaging in hematological malignancies; applications of FDG-...
Atlas of PET-CT
This new atlas, the fourth of a successful series, is a completely revised and updated edition of a previously published FDG PET-CT atlas. In the past few years, considerable progress has been made in the field of PET-CT imaging, and this new edition takes full account of these recent developments. Furthermore, its educational mission has been broadened: beyond serving as a straightforward guide to FDG PET-CT imaging it now encompasses the integrative use of contrast-enhanced CT and MRI. The new edition also includes non-oncological indications for FDG PET-CT. The atlas aims to help imaging practitioners to recognize physiological and benign pathological FDG uptake and illustrates in a case-based, practical manner the PET-CT appearances of all the major tumors and infectious, inflammatory, and neurodegenerative disorders. The main clinical applications are covered, and learning points and pitfalls are clearly articulated. The consistent, user-friendly format facilitates image interpretation and allows rapid review of key information needed for FDG PET-CT imaging.
Role of Medical Imaging in Cancers
The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine.
PET-CT Beyond FDG
Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research but also in clinical practice. This atlas, including about 500 high-quality images, is a user-friendly guide to PET-CT imaging beyond FDG. A wide range of tracers is covered, such as 18F- and 11C-choline, 11C-methionine, 18F-ethyl-L-tyrosine, 68Ga-DOTA-NOC, 11C-acetate, 11C-thymidine, and 18F-DOPA. Throughout, the emphasis is on image interpretation, with guidance on the recognition of normal, benign, and malignant uptake and clear instruction on learning points and pitfalls. This atlas is designed to serve as a reference text for both nuclear physicians and radiologists, and will also be of great benefit to radiographers, technologists, and nuclear medicine and radiology residents.
Advances in Urologic Imaging, An Issue of Urologic Clinics E-Book
Dr. Samir Taneja is serving as the Guest Editor for this issue that provides updated and technical content on imaging techniques in urology. Top experts provide clinical reviews on the following topics: Dual-Energy Computed Tomography in Genitourinary Imaging; Diffusion-Weighted Genitourinary Imaging; Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography; Imaging of Solid Renal Masses; Imaging of Cystic Renal Masses; Image-Guided Renal Interventions; Practical Approach to Adrenal Imaging; Technique of Multi-parametric MRI of the prostate; Multi-parametric MRI- Interpretation Including PIRADS v2; Prostate MRI for Staging; Prostate MRI for Post-Treatment Evaluation and Recurrence; Imaging of Prostate Cancer Using 11C-Choline PET/Computed Tomography; Imaging of Prostate Cancer Using Fluciclovine; and Gallium-68 Prostate-Specific Membrane Antigen PET Imaging. Readers will come away with a clearer understanding of how the latest imaging modalities are utilized for disease diagnosis and management.
Diagnostic Nuclear Medicine and Radionuclide Therapy
Nuclear medicine is a medical imaging specialty involving the use of radioactive compounds for diagnostic and therapeutic purposes. As a medical branch, it is considered part of Diagnostic Imaging, but differs substantially from Radiology with respect to the source of the radiation made visible by the diagnostic devices. Nuclear medicine adopts also some types of radioactive emissions for therapeutic purposes, allowing the employment of the metabolic properties of the radiopharmaceuticals for the cure of certain clinical conditions and malignant diseases. Nuclear medicine is a relatively recent discipline and owes its origins to the discovery of natural radioactivity and the development of t...
PET-CT: Rare Findings and Diseases
PET-CT is increasingly being employed in the diagnosis of both oncological and non-oncological patients, yet nuclear medicine physicians may have only limited practical experience of rare diseases and may experience difficulty in recognizing and interpreting rare findings. This unique atlas documents a large number of clinical cases that will help practitioners to identify findings and diseases that, though rare, are sufficiently frequent to be encountered in routine practice. Two types of cases are presented: patients evaluated for rare diseases and patients evaluated for standard diseases in whom atypical PET findings were detected. Each reported case includes a brief description of the clinical history, representative color PET-CT images obtained using FDG or other tracers, and a short explanation of the disease and findings. This atlas will enable practitioners to make conclusive reports of PET-CT scans that would otherwise have been inconclusive.
PET-CT-MRI Applications in Musculoskeletal Disorders, Part II, An Issue of PET Clinics
This issue of PET Clinics is Part II of a two-part issue, and focuses on PET-CT-MRI Applications of Musculoskeletal Disorders. It is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Ali Salavati, Ali Gholamrezanezhad and Ali Guermazi. Articles will include:Applications of PET-CT-MR in the management of benign musculoskeletal disorders; Diagnostic management of primary and secondary spinal neoplastic disease: The role of PET-CT-MRI; Skeletal Metastasis Evaluation: Value and impact of PET/CT on Diagnosis, Management and Prognosis; Hybrid imaging (PET CT/PET MRI) of bone metastases; Diffusion-weighted MR Imaging in Evaluating Bone Metastases; Imaging of Osteoarthritis by Conventional Radiography, MRI, PET-CT and PET-MRI; Evolving Role of MRI and PET in Assessing Osteoporosis; Evolving Role of Novel PET-CT-MRI based quantitative technique for Assessing Muscle Disorders; Pediatric musculoskeletal applications of PET-CT-MRI; In vivo molecular imaging of inflammation and infection; Future perspective of the application of PET-CT-MRI in musculoskeletal disorders; and more!
Advances in organ-specific PET instrumentation and their clinical and research applications, An Issue of PET Clinics, E-Book
In this issue of PET Clinics, guest editors Drs. Abass Alavi, Habib Zaidi, and Suleman Surti bring their considerable expertise to the topic of Advances in Organ-specific PET Instrumentation and Their Clinical Applications. Top experts cover key topics such as the increasing use of silicon photomultiplier (SiPM) technology, advances in depth-of-interaction (DOI) and time-of-flight (TOF) PET detectors, the use of artificial intelligence technologies for detector development; and more. Contains 11 relevant, practice-oriented topics including advances in PET detectors and readout technologies; whole-gamma imaging; clinical applications of dedicated brain PET; clinical applications of dedicated breast PET; potential clinical applications of dedicated prostate PET; and more. Provides in-depth clinical reviews on advances in organ-specific PET instrumentation and their clinical applications, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
